biotech
biotech Articles
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Published:
Last Updated:
Viamet Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get an added boost with any good news.
Published:
Last Updated:
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs to the clinic this year.
Published:
Last Updated:
Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help sentiment continue to turn around.
Published:
Last Updated:
This week's top U.S. growth calls from the analysts at Jefferies focus on companies that have some outstanding upside potential, including the following three leading biotech stocks.
Published:
Last Updated:
At the end of March, a district court granted the request from Depomed and lifted the stay of its patent infringement suit against Purdue.
Published:
Last Updated:
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well. One key analyst has decided to weigh in on the firm and where it stands to go from here.
Published:
Last Updated:
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
Akari Therapeutics has announced preliminary results from the first paroxysmal nocturnal hemoglobinuria patient treated with subcutaneously administered Coversin.
Published:
Last Updated:
Genocea Biosciences soared early on Thursday, following the release of positive data from its mid-stage genital herpes clinical trial.
Published:
Last Updated:
The SEC has announced that a San Francisco-based biotech venture capitalist will settle charges that he siphoned money from a fund managed by his firm in order to prop up other struggling businesses...
Published:
Last Updated:
Opko Health saw its shares slide in Wednesday’s regular trading session following the release of a complete response letter from the FDA.
Published:
Last Updated:
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Published:
Last Updated: